Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+104.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+104.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
35.6x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
20251960.61%
2024168.75%
202357.65%
2022-209.09%
202138.89%
202055.00%
20199.09%
201828.69%
201715.83%
2016-25.95%